• Translating Wnt Pathway Modulation: Precision with IWP-L6

  2026-07-01

  Explore how sub-nanomolar Porcupine inhibition with IWP-L6 empowers translational researchers to dissect the metabolic and developmental consequences of Wnt signaling, with a special focus on the mechanistic role of O-GlcNAcylation in bone formation. This article bridges advanced pathway biology, actionable experimental strategies, and a forward-looking perspective for regenerative and metabolic research.

• 3-Deazaadenosine Hydrochloride: Precision in Methylation Pat

  2026-07-01

  3-Deazaadenosine hydrochloride empowers researchers to dissect S-adenosylhomocysteine hydrolase-dependent methylation in liver fibrosis and beyond. This article translates cutting-edge findings into actionable protocols, highlighting APExBIO's reagent as a high-purity, workflow-enabling standard for advanced cell signaling, proliferation, and inflammation studies.

• Mithramycin A in Mechanistic Oncology: Beyond c-myc Inhibiti

  2026-06-30

  Explore how Mithramycin A, a potent anticancer antibiotic, transforms cancer biology research by targeting G-C-rich DNA and modulating transcriptional networks. This article unveils unique mechanistic insights and practical assay considerations, setting it apart from standard protocol guides.

• Fucoidan: Mechanistic Insights and Oncology Workflow Integra

  2026-06-30

  Fucoidan, a sulfated α-L-fucan from brown seaweed, demonstrates robust anticancer and immune-modulating effects via well-characterized molecular pathways. Peer-reviewed evidence supports its role in apoptosis induction, angiogenesis inhibition, and NK cell activation, particularly in prostate and breast cancer models. This article details verifiable benchmarks, addresses application boundaries, and provides actionable workflow parameters for research use.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio

  2026-06-29

  Wang et al. (2025) reveal that the mitochondrial co-chaperone TCAIM specifically binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, altering mitochondrial metabolism. This work uncovers a new post-translational regulatory mechanism affecting cellular energetics and metabolic signaling.

• Hypothalamic SLC7A14 Controls Age-Related Lipolysis Impairme

  2026-06-29

  This study reveals that decreased hypothalamic SLC7A14 expression in aged male mice directly impairs white adipose tissue lipolysis, identifying a central mechanism involving POMC neurons, mTORC1 signaling, and bile acid metabolism. The findings provide critical insight into the brain–gut–adipose axis in age-associated obesity, highlighting potential molecular targets for intervention.

• Dissecting Drug-Induced Cell Death: Insights from MEDUSA Scr

  2026-06-28

  Honeywell et al. introduce MEDUSA, a simulation-assisted approach that distinguishes growth and death rates in pooled functional genomic screens, revealing precise mechanisms of drug-induced lethality. This advance clarifies how both apoptotic and non-apoptotic pathways are regulated, with broad implications for cancer research and targeted therapy design.

• RRP Extracts Mitigate Liver Ischemia-Reperfusion Injury via

  2026-06-27

  This study demonstrates that Radix Rehmanniae Praeparata (RRP) extracts ameliorate hepatic ischemia-reperfusion injury (HIRI) in mice by restoring lipid metabolism in hepatocytes. Mechanistically, RRP activates AMPK, suppresses SREBP2-mediated cholesterol synthesis, and promotes LXRα-dependent cholesterol efflux, offering mechanistic insight for future therapeutic development and experimental modeling.

• Indole-3-pyruvic Acid: Protocols and Innovations in Immune a

  2026-06-26

  Indole-3-pyruvic acid (IPA) stands out as a metabolic linchpin in both plant hormone biosynthesis and immune modulation workflows, offering precise control over auxin pathways and targeted immune responses. This article delivers actionable protocols, troubleshooting strategies, and integrative insights to maximize IPA’s impact from bench to translational research.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows Against H5N1

  2026-06-26

  This study demonstrates the safety and robust protective efficacy of a hemagglutinin-based mRNA–lipid nanoparticle vaccine in lactating dairy cows challenged with H5N1 influenza. The findings establish a foundation for further development of mRNA vaccine strategies to mitigate zoonotic influenza threats in livestock.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-06-25

  The reference study identifies mitogen-activated protein kinase 10 (MAPK10) as a key suppressor of non-small cell lung cancer (NSCLC) metastasis, acting through phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). This mechanistic insight highlights the MAPK10/KRT16/RNF213 axis as a promising target for prognostic and therapeutic strategies in NSCLC.

• CDC42 Polarity Controls Intestinal Stem Cell Fate via YAP-mT

  2026-06-25

  The referenced study uncovers how CDC42-regulated apical-basal polarity directs the fate balance between intestinal stem cells and transit amplifying cells through a Hippo-YAP-EGF-mTOR signaling cascade, independent of canonical Wnt signaling. These insights clarify mechanisms governing epithelial homeostasis and provide new frameworks for dissecting gastrointestinal stem cell dynamics.

• CUDC-907: Technical Protocols for Dual PI3K and HDAC Inhibit

  2026-06-24

  CUDC-907 is a dual PI3K and HDAC inhibitor for in vitro cancer research, enabling precise modulation of PI3K/AKT and histone deacetylase pathways. It is not suitable for diagnostic or clinical applications and should be restricted to controlled laboratory workflows.

• Mechanisms of Propranolol Action in Essential Tremor Therapy

  2026-06-23

  This study uses transcranial magnetic stimulation to elucidate the central and peripheral mechanisms by which propranolol and primidone alleviate essential tremor. The findings clarify propranolol’s role in modulating corticospinal excitability and GABAergic circuits, offering a refined framework for future therapeutic development.

• Trichostatin A (TSA): Applied Epigenetic Modulation in Cance

  2026-06-23

  Trichostatin A (TSA) empowers researchers to precisely modulate chromatin states, unlocking advanced cancer and differentiation workflows. This article translates the latest mechanistic insights into actionable protocols and troubleshooting strategies, with a focus on ferroptosis sensitivity and cell cycle arrest.

16139 records 1/1076 page Next 12345 下5页 Last page